WNT5A and melanoma: In contrast, Wnt5a, which activates the β-catenin-independent pathway, has been shown to exhibit elevated expression in cancer cells; elevated expression of Wnt5a is associated with progression of melanoma and lung, gastric, breast and prostate cancers8, 9, 10, 11, 12, 13, 14.